Latest BioPharm Stories
SOUTH SAN FRANCISCO, Calif., Sept.
Who will be the next big biotech success? Washington, DC (PRWEB) September 04, 2014 The “Fierce 15,” FierceBiotech’s annual list of the industry’s
Infinata’s leading life sciences publication highlights activity from the nation’s top law firms, revealing 3Q13 licensing activity decreased by 18% in value compared to 2Q13. Norwood,
Infinata division hosts educational webinar entitled “Pre-ASH Crash Course” to cover biopharmaceutical trends and highlights ahead of the scientific meeting. Norwood,
Infinata division collects findings from pharmaceutical industry experts and KOLs at the recent European Respiratory Society Annual Congress in Barcelona, Spain Norwood,
In-demand research report “Mass Spectrometry 2013: A Focus on Sales Growth” worked out by Biopharm Reports has been recently published by Market Publishers Ltd. London,
Leading private cloud hosting services provider for Oracle’s clinical trial and drug safety software recognized as one of the top 52 fastest-growing companies. San
Award-winning journalist, Kimberly Ha, will gather healthcare investors to offer actionable opportunities and advice for pre-clinical and Phase I drug development companies. Norwood,
Award-winning journalist, Kimberly Ha, to draw practical advice and strategies from top pharmaceutical industry deal makers. Norwood, MA (PRWEB) October 16,
Report uncovers results and trends unavailable from any other news service and before pharmaceutical company disclosures; webinar speakers include former director of FDA’s Office of Orphan Drugs.
- A transitional zone between two communities containing the characteristic species of each.